early alzheimer’s research team awarded $3.8m grant for precision robotics 
 the team will use the technology to uncover the emergence of cellular and circuit dysfunction during the progression of alzheimer’s. 
 a robotically controlled glass electrode enables single-cell electrical recordings in living brain tissue. credit: georgia tech 
 oct 12, 2022 
 — atlanta, ga 
 by 2050, more than 150 million people are projected to be living with dementia. alzheimer’s disease, the most common form of dementia, makes up roughly 70% of all cases. alzheimer’s causes progressive neurodegeneration – a hallmark of the disease which is thought to initiate and track cognitive decline in those suffering with it. but while increasingly accurate biochemical markers are helping diagnose alzheimer’s disease earlier, treatments to stall the disease in its early stages remain elusive. 
 read the rest of the story here . 
 additional images 
 contact 
 catherine barzler 
 senior research writer / editor 
 institute communications 
 email 
 catherine.barzler@gatech.edu 
 georgia institute of technology 
 north avenue atlanta, ga 30332 
 +1 404.894.2000